Protalix BioTherapeutics (PLX) Other financing activities (2010 - 2016)
Protalix BioTherapeutics' (PLX) quarterly Other financing activities came in at $14000.0 in Q4 2016, down 54.84% quarter-over-quarter from $31000.0 in Q1 2014.
Protalix BioTherapeutics (PLX) Other financing activities (2010 - 2016) Analysis & Trends
Protalix BioTherapeutics' Other financing activities history runs 6 years deep, the most recent figure standing at $14000.0 for Q4 2016.
- On a quarterly basis, Other financing activities changed N/A year-over-year to $14000.0 in Q4 2016; TTM through Dec 2022 was $14000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $712000.0, up 35500.0% from the prior year.
- Other financing activities retreated to $14000.0 in Q4 2016 per PLX's latest filing, from $31000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $1.0 million in Q2 2012 and bottomed at $2000.0 in Q2 2013.
- The 4-year median for Other financing activities is $31000.0 (2014), against an average of $154111.1.
- Across the five-year window, Other financing activities surged 34900.0% in 2012 and slumped 99.81% in 2013, its largest moves.
- Year by year, Other financing activities stood at $134000.0 in 2012, then plunged by 38.81% to $82000.0 in 2013, then tumbled by 62.2% to $31000.0 in 2014, then plunged by 54.84% to $14000.0 in 2016.
- Per Business Quant, the three latest PLX Other financing activities figures stand at $14000.0 (Q4 2016), $31000.0 (Q1 2014), and $82000.0 (Q4 2013).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Protalix BioTherapeutics | 190.95 Mn | 180.16 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 14,000.00 |
| Dec 31, 2016 | 14,000.00 |
| Mar 31, 2014 | 31,000.00 |
| Mar 31, 2014 | 31,000.00 |
| Dec 31, 2013 | 82,000.00 |
| Dec 31, 2013 | 82,000.00 |
| Jun 30, 2013 | 2,000.00 |
| Jun 30, 2013 | 2,000.00 |
| Mar 31, 2013 | 28,000.00 |
| Mar 31, 2013 | 28,000.00 |
| Dec 31, 2012 | 134,000.00 |
| Dec 31, 2012 | 134,000.00 |
| Sep 30, 2012 | 10,000.00 |
| Sep 30, 2012 | 10,000.00 |
| Jun 30, 2012 | 1.05 Mn |
| Jun 30, 2012 | 1.05 Mn |
| Mar 31, 2012 | 36,000.00 |
| Mar 31, 2012 | 36,000.00 |
| Dec 31, 2011 | 14,000.00 |
| Dec 31, 2011 | 14,000.00 |